Modulation of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by Chemotherapy in Thyroid Cancer Cell Lines

Thyroid

Volumn 13, Issue 12, 2003, Pages 1103-1110

  Park, Jin Woo ^a,b   Wong, Mariwil G ^a   Lobo, Margaret ^a   Hyun, William C ^c   Dun, Quan Yang ^d   Clark, Orlo H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chungbuk National University   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; GELDANAMYCIN; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TROGLITAZONE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; ASSAY; CANCER CELL; CANCER CHEMOTHERAPY; CELL DEATH; DRUG EFFECT; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; THYROID CANCER; WESTERN BLOTTING;

EID: 0347993697     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250360731497     Document Type: Article

References (29)

1. Bretz JD, Rymaszewski M, Arscott PL, Myc A, Ain KB, Thompson NW, Baker JR Jr 1999 TRAIL death pathway expression and induction in thyroid follicular cells. J Biol Chem 274:23627-23632.
2. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I 2000 Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 60:4122-4129.
3. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ 1998 Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161:2833-2840.
4. Langaas V, Shahzidi S, Johnsen JI, Smedsrod B, Sveinbjornsson B 2001 Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells. Anticancer Res 21:3733-3738.
5. Munshi A, McDonnell TJ, Meyn RE 2002 Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells. Cancer Chemother Pharmacol 50:46-52.
6. Goretzki PE, Frilling A, Simon D, Roeher HD 1990 Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res 118:48-63.
7. Zielke A, Tezelman S, Jossart GH, Wong M, Siperstein AE, Duh Q-Y, Clark OH 1998 Establishment of a highly differentiated thyroid cancer cell line of Hürthle cell origin. Thyroid 8:475-483.
8. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA 77:3455-3459.
9. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA 1995 Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682.
10. Tartaglia LA, Goeddel DV 1992 Two TNF receptors. Immunol Today 13:151-153.
11. Nagata S 1997 Apoptosis by death factor. Cell 88:355-365.
12. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH 1999 Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163.
13. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH 1999 Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155-162.
14. Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ 2002 Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 168:1356-1361.
15. Takimoto R, El-Deiry WS 2000 Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19:1735-1743.
16. Guan B, Yue P, Clayman GL, Sun SY 2001 Evidence that the death receptor DR4 Is a DNA damage-inducible, p53-regulated gene. J Cell Physiol 188:98-105.
17. Sheikh MS, Huang Y, Fernandez-Salas EA, El-Deiry WS, Friess H, Amundson S, Yin J, Meltzer SJ, Holbrook NJ, Fornace AJ Jr 1999 The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract. Oncogene 18:4153-4159.
18. Meng RD, McDonald ER 3rd, Sheikh MS, Fornace AJ Jr, El-Deiry WS 2000 The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis. Mol Ther 1:130-144.
19. Kim K, Fisher MJ, Xu SQ, el-Deiry WS 2000 Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res 6:335-346.
20. Jossart GH, Epstein HD, Shaver JK, Weier HU, Greulich KM, Tezelman S, Grossman RF, Siperstein AE, Duh QY, Clark OH 1996 Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines. J Clin Endocrinol Metab 81:3498-3504.
21. Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S 1999 Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59:734-741.
22. Kim MR, Lee JY, Park MT, Chun YJ, Jang YJ, Kang CM, Kim HS, Cho CK, Lee YS, Jeong HY, Lee SJ 2001 Ionizing radiation can overcome resistance to TRAIL in RAIL-resistant cancer cells. FEBS Lett 505:179-184.
23. Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N 2002 Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Am J Pathol 161:643-654.
24. Martelli ML, Iuliano R, Le Pera I, Monaco C, Cammarota S, Kroll T, Chiariotti L, Santoro M, Fusco A 2002 Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth. J Clin Endocrinol Metab 87:4728-4735.
25. Park JW, Yeh MW, Wong MW, Duh QY, Clark OH 2001 The benzoquinone ansamycin geldanamycin induces cytotoxicity and inhibits tumor invasion by epidermal growth factor in human thyroid cancer cell lines [abstract]. Presented at the 73rd Annual Meeting of the American Thyroid Association 2001.
26. Ain KB, Tofiq S, Taylor KD 1996 Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo. J Clin Endocrinol Metab 81:3650-3653.
27. Fulda S, Meyer E, Debatin KM 2002 Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21:2283-2294.
28. Ravi R, Bedi A 2002 Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: Synergism with sulindac-mediated inhibition of Bcl-x(L). Cancer Res 62:1583-1587.
29. Ravi R, Bedi A 2002 Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Cancer Res 62:4180-4185.